JP2021518379A5 - - Google Patents
Info
- Publication number
- JP2021518379A5 JP2021518379A5 JP2020550114A JP2020550114A JP2021518379A5 JP 2021518379 A5 JP2021518379 A5 JP 2021518379A5 JP 2020550114 A JP2020550114 A JP 2020550114A JP 2020550114 A JP2020550114 A JP 2020550114A JP 2021518379 A5 JP2021518379 A5 JP 2021518379A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- pyrimidine
- pyrrolo
- azaspiro
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862646167P | 2018-03-21 | 2018-03-21 | |
| US62/646,167 | 2018-03-21 | ||
| PCT/US2019/022657 WO2019182924A1 (en) | 2018-03-21 | 2019-03-18 | Jak inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021518379A JP2021518379A (ja) | 2021-08-02 |
| JP2021518379A5 true JP2021518379A5 (cg-RX-API-DMAC7.html) | 2022-03-30 |
| JP7462951B2 JP7462951B2 (ja) | 2024-04-08 |
Family
ID=67986579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020550114A Active JP7462951B2 (ja) | 2018-03-21 | 2019-03-18 | Jak阻害剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11365188B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3768272B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7462951B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN111936144B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019237991B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3093706A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019182924A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102218333B1 (ko) | 2016-06-07 | 2021-02-22 | 자코바이오 파마슈티칼스 컴퍼니 리미티드 | Shp2 억제제로서 유용한 신규한 헤테로환형 유도체 |
| SG11201908820VA (en) | 2017-03-23 | 2019-10-30 | Jacobio Pharmaceuticals Co Ltd | Novel heterocyclic derivatives useful as shp2 inhibitors |
| CN112839935A (zh) | 2018-09-26 | 2021-05-25 | 北京加科思新药研发有限公司 | 可用作shp2抑制剂的新型杂环衍生物 |
| JP2022506682A (ja) * | 2018-11-05 | 2022-01-17 | アビスタ ファーマ ソリューションズ,インコーポレーテッド | 化合物 |
| CN113498352A (zh) | 2019-01-23 | 2021-10-12 | 施万生物制药研发Ip有限责任公司 | 作为jak抑制剂的咪唑并[1,5-a]吡啶、1,2,4-三唑并[4,3-a]吡啶和咪唑并[1,5-a]吡嗪 |
| DK3915989T3 (da) | 2019-01-30 | 2023-09-18 | Felicamed Biotechnology Co Ltd | Jak inhibitor and preparation method therefor |
| TW202227452A (zh) * | 2020-12-04 | 2022-07-16 | 大陸商廣州費米子科技有限責任公司 | 氮雜並環化合物、其製備方法、抑制酪氨酸激酶的方法、藥物組成物及其用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6075736B2 (ja) | 2011-12-21 | 2017-02-08 | ジエンス ヘンルイ メデイシンカンパニー リミテッドJiangsu Hengrui Medicine Co.,Ltd. | ピロール−6員ヘテロアリール環誘導体、その合成法およびその医薬用途 |
| LT3077395T (lt) | 2013-12-05 | 2018-02-12 | Pfizer Inc. | Pirolo[2,3-d]pirimidinilo, pirolo[2,3-b]pirazinilo ir pirolo[2,3-d]piridinilo akrilamidai |
| US9340540B2 (en) | 2014-02-28 | 2016-05-17 | Nimbus Lakshmi, Inc. | TYK2 inhibitors and uses thereof |
| WO2016024185A1 (en) * | 2014-08-12 | 2016-02-18 | Pfizer Inc. | Pyrrolo[2,3-d]pyrimidine derivatives useful for inhibiting janus kinase |
| ES2962330T3 (es) | 2015-01-20 | 2024-03-18 | Wuxi Fortune Pharmaceutical Co Ltd | Inhibidor de jak |
| WO2018169700A1 (en) | 2017-03-14 | 2018-09-20 | Sunshine Lake Pharma Co., Ltd. | Substituted heteroaryl compounds and methods of use |
-
2019
- 2019-03-18 WO PCT/US2019/022657 patent/WO2019182924A1/en not_active Ceased
- 2019-03-18 JP JP2020550114A patent/JP7462951B2/ja active Active
- 2019-03-18 CN CN201980020463.5A patent/CN111936144B/zh active Active
- 2019-03-18 EP EP19770607.0A patent/EP3768272B1/en active Active
- 2019-03-18 AU AU2019237991A patent/AU2019237991B2/en active Active
- 2019-03-18 CA CA3093706A patent/CA3093706A1/en active Pending
- 2019-03-18 US US16/979,455 patent/US11365188B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2016328619B2 (en) | Heterocyclic compounds and uses thereof | |
| EP3468972B1 (en) | Compounds and compositions for inhibiting the activity of shp2 | |
| JP6695353B2 (ja) | Fgfr4阻害剤としてのホルミル化n−複素環式誘導体 | |
| TWI579284B (zh) | 咪唑并吡咯啶酮化合物 | |
| JP2024522345A (ja) | ウェルナー症候群RecQヘリカーゼ(WRN)の阻害に関連する疾患を治療するためのトリアゾロ-ピリミジン類似体 | |
| CN118974055A (zh) | 作为突变kras蛋白抑制剂的喹唑啉化合物及其用途 | |
| JP2013523884A5 (cg-RX-API-DMAC7.html) | ||
| JP2013515070A5 (cg-RX-API-DMAC7.html) | ||
| AU2017286654A1 (en) | Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases | |
| JP2025536259A (ja) | 三環式化合物及びその使用 | |
| EP3710002A2 (en) | Degraders and degrons for targeted protein degradation | |
| HRP20140770T1 (hr) | SUPSTITUIRANI SPOJEVI N-(1H-INDAZOL-4-IL)IMIDAZO[1,2-a]PIRIDIN-3-KARBOKSAMIDA KAO INHIBITORI CFMS | |
| EP4237086A1 (en) | Heterocyclic spiro compounds and methods of use | |
| CN108430993A (zh) | Tank-结合激酶抑制剂化合物 | |
| RU2013136778A (ru) | Ингибиторы гистондезацетилазы, композиции и способы их применения | |
| JP2024536858A5 (cg-RX-API-DMAC7.html) | ||
| JP2012515737A (ja) | メトトレキサートおよびdhodh阻害剤を含む組合せ剤 | |
| CN111051305A (zh) | 治疗性杂环化合物 | |
| CA2904797A1 (en) | Combination of an egfr t790m inhibitor and an egfr inhibitor for the treatment of non-small cell lung cancer | |
| JP2006512366A5 (cg-RX-API-DMAC7.html) | ||
| EP3994132A1 (en) | Tyrosine kinase non-receptor 1 (tnk1) inhibitors and uses thereof | |
| JP2021514011A5 (cg-RX-API-DMAC7.html) | ||
| RU2015102537A (ru) | Цианогуанидины и их применение в качестве противовирусных средств | |
| RU2014105177A (ru) | Новое соединение, проявляющее ингибиторную активность в отношении parp | |
| RU2006138606A (ru) | Ингибиторы киназы |